AbbVie ROA - Return on Assets 2010-2025 | ABBV

AbbVie return on assets for the quarter ending March 31, 2025 was 2.99.

  • AbbVie average return on assets for 2024 was 3.65, a 27% decline from 2023.
  • AbbVie average return on assets for 2023 was 5, a 42.66% decline from 2022.
  • AbbVie average return on assets for 2022 was 8.72, a 68.34% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

AbbVie ROA - Return on Assets 2010-2025 | ABBV

  • AbbVie average return on assets for 2024 was 3.65, a 27% decline from 2023.
  • AbbVie average return on assets for 2023 was 5, a 42.66% decline from 2022.
  • AbbVie average return on assets for 2022 was 8.72, a 68.34% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B